• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Business News

Latest business breaking news from around the world

  • Home
  • Markets
  • Business
  • Investing
  • Tech
  • Politics

Perfect marketing

U.S. Prescription Drug Pricing Doesn’t Favor The Patient: Case Of Sub-Optimal Market For Cancer Pharmaceuticals

August 3, 2022 by www.forbes.com

Share to Twitter Share to Linkedin The high costs of cancer drugs impact patients negatively. In fact, the out-of-pocket cost burden can be “ financially toxic ” to patients, causing personal bankruptcy or simply take a substantial bite out of people’s discretionary income. Should the Inflation Reduction Act pass later this month, the imposition of a $2,000 cap on Medicare beneficiary out-of-pocket spending on outpatient drugs would address the issue of financial toxicity to some degree, at least for one segment (Medicare) of the market. Currently, 1.5 million medicare beneficiaries pay more than $2,000 out-of-pocket for prescription drugs, while 1.3 million spend more than $7,000. Many of these Medicare beneficiaries are cancer patients. High patient out-of-pocket costs aren’t just a reflection of a poorly designed Medicare prescription drug benefit. More generally, they also reflect a market for cancer drugs which doesn’t function optimally. … [Read more...] about U.S. Prescription Drug Pricing Doesn’t Favor The Patient: Case Of Sub-Optimal Market For Cancer Pharmaceuticals

Filed Under: Healthcare cancer drugs, 340B, Medicare, financial toxicity, drug pricing, PBMs, rebates, Healthcare, ..., raises cancer drug price, promising cancer drugs may speed tumours in some patients, patient right to know drug prices act, prescriptions cancer patients, favor doesn't show price, why doesn't favor tell you the price, price gouging on prescription drugs, wholesale prescription drug prices, high priced prescription drugs, value pricing for market access evidence-based pricing for pharmaceuticals, lower priced prescription drugs, drug company faked cancer patients to sell drug, prescription drug price relief act, prescription drug marketing act, prescription drug prices in europe, c-span prescription drug prices, prescription drug prices medicare part d

POV: Yes, there are enough hours in a day—if you manage your time better

August 7, 2022 by www.fastcompany.com

“There are not enough hours in the day!” advertisement advertisement We’ve all, at some point, have exclaimed that in exasperation. But guess what: it doesn’t have to be true. Time is one of the most significant professional considerations leaders have as they look to do more and amplify their impact. Cracking the code on time is especially relevant to professionals at a crossroads, those ready for their next promotion, looking to join the C-suite, or scale up their leadership or business. A Stanford study found that productivity per hour declines when we work too much. People who work 70 or more hours a week get the same amount of work done as those who work 55 hours. We all have the same 24 hours in the day, yet some individuals can accomplish much more. But how? Prioritize planning Prioritization is not just about what needs to be done but whether you are focusing your time and attention to work on the most important goals you need … [Read more...] about POV: Yes, there are enough hours in a day—if you manage your time better

Filed Under: Uncategorized Work Life, byline, better time management, better time management skills, better manage time, managing time better, strategies for better time management, hourly time management template, manage time better, antibiotics 3 times a day or every 8 hours

How to decide if a business issue is worth solving

September 21, 2021 by www.fastcompany.com

Managing time is one of a CEO’s greatest challenges, but it’s not just their own time they are responsible for. One of a leader’s main responsibilities is setting a clear strategy for their organization, and good strategy is about making choices among competing priorities. advertisement advertisement With finite resources and numerous problems to fix, organizations can become inefficient without clear direction. It’s the CEO’s job to provide that direction for the use of limited resources. But with issues, opportunities, and initiatives popping up all the time, it’s not always easy to prioritize. Companies face issues in supply chain, marketing, product, quality, and entering new markets, to name a few. So how can a leader know which issues are most worth addressing? As a business unit leader for Fortune 500 companies, I saw many scenarios where the leadership team needed to decide between competing priorities. Over time, I developed a series of … [Read more...] about How to decide if a business issue is worth solving

Filed Under: Uncategorized Tech, byline_Kevin Namaky, solve that issue, when this issue will solve, issue to solve, responding to healthcare's most urgent business issues, system where residents vote to decide an issue, is business minor worth it, about wicked problems problems worth solving, playboy issues worth money, playboy 50th anniversary issue worth, technological business issues, evaluating how much a business is worth, appellate courts decide which issues to address based on, ted 8 business books worth reading, debatable business issues, silver surfer 50th anniversary issue worth, micro businesses issues, issues decided at the constitutional convention, why scalability is a key business issue for websites, minority business issues, environmental business issues

Primary Sidebar

RSS Recent Stories

  • GPS aims for perfect score in GE15 – chairman
  • US government poised for long-awaited powers on drug pricing
  • China IPO market trounces the world with record US$58b boom
  • My message from Hiroshima
  • Asian Pac positions Surya PJ South to transform Taman Medan
  • Magat Dam to release water in anticipation of heavy rains
  • Tycoons pay tribute to FVR
  • Signing up with South Korean company a full-circle moment for 4th Impact
  • Ben&Ben beyond soaring melodies, crowd-pleasing musicality
  • Loveless actor puts ‘extracurricular’ activities on hold

Sponsored Links

Copyright © 2022 Business News. Power by Wordpress.
Home - About Us - Contact Us - Disclaimers - DMCA - Privacy Policy - Submit your story